Start-Up Quarterly Statistics, Q4 2015

26 Feb 2016

• By Deanna Kamienski

Start-ups raised $2.41 billion in Q4 2015. Biopharma companies penned 29 alliances; seven acquisitions were signed in the biopharma and diagnostics industries.

During the final quarter of 2015, start-up companies raised a total of $2.41 billion, $156 million less than the previous quarter but a 65% increase from Q4 2014's total of $1.46 billion. Forty-five biopharma companies combined for $2.24 billion, about 50% resulting from Series As ($1.17 billion). Two medical device firms together raised $63.5 million in Series B financing, accounting for half of the total $126.6 million in device funding. Five in vitro diagnostics start-ups pulled in $45.2 million. (See Exhibit 1.)

To date, 2015 saw the most fundraising ($10.33 billion in all), and Q1 remains the highest quarterly total on record...